Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Operating Activities

    Back to Cashflow Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Operating Activities ₹-265 Cr₹625 Cr₹1,109 Cr₹1,131 Cr₹1,392 Cr

What is the latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS is ₹-265 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Operating Activities
Mar2024₹-265 Cr
Mar2023₹625 Cr
Mar2022₹1,109 Cr
Mar2021₹1,131 Cr
Mar2020₹1,392 Cr

How is Cash Flow from Operating Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Operating Activities % Change
Mar2024 ₹-265 Cr
Negative
Mar2023 ₹625 Cr
-43.59
Mar2022 ₹1,109 Cr
-1.99
Mar2021 ₹1,131 Cr
-18.76
Mar2020 ₹1,392 Cr -

Compare Cash Flow from Operating Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,999.4 Cr -3.9% -9.7% 57.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,692.0 Cr -5.3% -7.8% 24.1% Stock Analytics
DIVIS LABORATORIES ₹149,215.0 Cr -3.9% -7.9% 51% Stock Analytics
CIPLA ₹115,000.0 Cr -1.9% -6.9% 3.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,616.4 Cr -8.3% -14.9% 0.8% Stock Analytics
ZYDUS LIFESCIENCES ₹93,841.4 Cr -5.7% -4% 23.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-3.9%

-9.7%

57.2%

SENSEX

0.2%

-2.2%

7.7%


You may also like the below Video Courses